Table 1. Patient and tumor characteristics of 15 head-and-neck cancer patients.
Age (y)* | 15, 57.0, 55.8 ± 7.5 (45.0–68.0) |
Smoking (pack-years) | 15, 36.0, 47.4 ± 29.0 (10.0–100.0) |
Treatment elapsed (d) | 15, 47.0, 50.4 ± 7.0 (42.0–66.0) |
GTV-tumor – primary (cm3) | 14, 15.7, 39.5 ± 44.4 (2.9–162.5) |
GTV-tumor – nodal (cm3) | 10, 21.0, 47.0 ± 58.7 (2.4–179.8) |
GTV-tumor – max (cm3) | 15, 39.5, 60.1 ± 55.2 (8.8–179.8) |
Sex | |
Male | 12 (80.0) |
Female | 3 (20.0) |
Race | |
White | 8 (53.3) |
Black | 5 (33.3) |
Other | 2 (13.3) |
T stage | |
T0 | 1 (6.7) |
T1 | 1 (6.7) |
T2 | 6 (40.0) |
T3 | 3 (20.0) |
T4 | 4 (26.7) |
Nodal stage | |
N0 | 5 (33.3) |
N1 | 1 (6.7) |
N2 | 8 (53.3) |
N3 | 1 (6.7) |
M stage | |
M0 | 14 (93.3) |
M1 | 1 (6.7) |
AJCC stage | |
I | 0 |
II | 2 (13.3) |
III | 3 (20.0) |
IV | 10 (66.7) |
Total dose (Gy)/fractions | |
69.96/33 | 13 (86.7) |
70.00/35 | 1 (6.7) |
72.00/42 | 1 (6.7) |
Primary site | |
Nasopharynx | 2 (13.3) |
Oropharynx/oral | 6 (40.0) |
Hypopharynx/larynx | 5 (33.3) |
Other | 2 (13.3) |
Abbreviations: AJCC = American Joint Committee on Cancer; GTV = gross tumor volume; max = maximum of primary or nodal GTV.
Data in first six rows presented as n, median, mean ± SD (range). Other data presented as n (%).